Justin Hunter, MD
Vascular Surgery · Memphis, TNNPI 1154715134
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Abbott at 28.9% of the total. Reporting peaked in 2024 at $3,632 and has fallen 88.6% since, to $414 in 2025.
Across 60 payments — averaging $134.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- W. L. Gore & Associates, Inc.$2K
- Penumbra, Inc.$2K
- Medtronic$980
- Shockwave Medical, Inc$675
- Endologix LLC$174
- plus $400 from 7 others
What the payments were for
- Travel & lodging$4,41355%
- Food & beverage$3,35342%
- Education$3124%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $2,334 |
| W. L. Gore & Associates, Inc. | 14 | $1,879 |
| Penumbra, Inc. | 6 | $1,637 |
| Medtronic(2 entities) | 7 | $980 |
| Shockwave Medical, Inc | 6 | $675 |
| Endologix LLC | 2 | $174 |
| Angiodynamics, Inc. | 2 | $122 |
| Silk Road Medical, Inc. | 1 | $111 |
| Boston Scientific | 4 | $66 |
| Davol Inc. | 1 | $34 |
| Philips North America LLC | 1 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Smith+Nephew | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RUBY Coil$1,561
- OMNILINK ELITE$989
- SUPERA$974
- GORE TAG Thoracic Branch Endoprosthesis$766
- GORE TAG Thoracic Endoprosthesis$749
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$532
- ENDURANT IIS$513
- ELLIPSYS VASCULAR ACCESS SYSTEM$148
- ENDOCROSS Device$143
- Torus Stent Graft System$143
- Endurant$121
- ENROUTE Transcarotid Stent$111
- ENROUTE Transcarotid Neuroprotection System$111
- Auryon Laser System 100-120 Vac$108
How this compares
$8,079 in reported general payments places this provider in the 55th percentile of 117 vascular surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $13,047 |
| Cilostazol | 16 | $286 |
| ClopidogrelClopidogrel Bisulfate | 33 | $259 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Memphis
- James GardnerMemphis$18K
- Jorge Weber GuzmanMemphis$15K
- Spyridon MonastiriotisMemphis$10K
- Randall FranzMemphis$10K
- Shaun StickleyMemphis$8K
- Sira DusonMemphis$6K
- Daniel ClairNashville$993K
- Anton Dias PereraGermantown$832K
- Bryan FisherHendersonville$417K
- Christopher LesarChattanooga$311K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.